1985
DOI: 10.1126/science.2858129
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in L-Glutamate Binding in Alzheimer's and Huntington's Diseases

Abstract: Brain sections from patients who had died with senile dementia of the Alzheimer's type (SDAT), Huntington's disease (HD), or no neurologic disease were studied by autoradiography to measure sodium-independent L-[3H]glutamate binding. In brain sections from SDAT patients, glutamate binding was normal in the caudate, putamen, and claustrum but was lower than normal in the cortex. The decreased cortical binding represented a reduction in numbers of binding sites, not a change in binding affinity, and appeared to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
89
1

Year Published

1986
1986
2012
2012

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 325 publications
(93 citation statements)
references
References 42 publications
3
89
1
Order By: Relevance
“…The neurotransmitter utilized in corticocortical circuits is believed to be an excitatory amino acid (Baughman and Gilbert,198 1;Fonnum et al,198 1;Hicks and Geddes,198 1). Recent studies have demonstrated in AD the loss of both glutamate (Greenamyre et al, 1985) and aspartate (Palmer et al, 1986) receptors in the neocortex, a profound decrease in glutamate levels in the terminal field of the perforant pathway (Hyman et al, 1986) and the presence of NFT in glutamate-immunoreactive neurons (Maragos et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…The neurotransmitter utilized in corticocortical circuits is believed to be an excitatory amino acid (Baughman and Gilbert,198 1;Fonnum et al,198 1;Hicks and Geddes,198 1). Recent studies have demonstrated in AD the loss of both glutamate (Greenamyre et al, 1985) and aspartate (Palmer et al, 1986) receptors in the neocortex, a profound decrease in glutamate levels in the terminal field of the perforant pathway (Hyman et al, 1986) and the presence of NFT in glutamate-immunoreactive neurons (Maragos et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…66 More recently, decreases in glutamate receptors from the caudate and putamen isolated from HD patients were reported. 67 These findings probably reflected the loss of cells in the same brain regions that typically occur in HD. Bioenergetic defects, such as mitochondrial metabolic dysfunction, have also been reported in HD brain.…”
Section: Huntington's Diseasementioning
confidence: 95%
“…Several neurotransmitters, including cholinergic markers, noradrenergic markers, somatostatin, GABA, 5-HT, glutamate, neuropeptide Y, and CRF, are all reportedly diminished in AD, with apparent sparing of VIP, CCK, TRH, and LHRH content (see 5, 33, 63,64,78,103,115). Both cholinergic markers and many of the putative peptide transmitters have been found within or near NPs (131).…”
Section: Neurochemical Alterations In Alzheimer's Diseasementioning
confidence: 99%